ArticleDiagnostics (Basel, Switzerland)2023
Enhancement of Diabetic Retinopathy Prognostication Using Deep Learning, CLAHE, and ESRGAN.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A clinically interpretable deep learning pipeline for diabetic retinopathy classification using EfficientNet, advanced data augmentation and GradCAM.BMC ophthalmology · 2026Article
- Cloud edge enabled stacked ensemble learning framework with meta model for situation aware maritime traffic monitoring and control systems.Scientific reports · 2025Article
- Forecasting the diabetic retinopathy progression using generative adversarial networks.Communications medicine · 2025Article
- Deep learning based binary classification of diabetic retinopathy images using transfer learning approach.Journal of diabetes and metabolic disorders · 2024Article
- Enhancement of Diabetic Retinopathy Prognostication Using Deep Learning, CLAHE, and ESRGAN.Diagnostics (Basel, Switzerland) · 2023Article
- Deep Learning-Based Prediction of Diabetic Retinopathy Using CLAHE and ESRGAN for Enhancement.Healthcare (Basel, Switzerland) · 2023Article
Corrections and comments
- Retracted
- Retracted
Authors and funding
3 authors.
Funding
Abstract
One of the primary causes of blindness in the diabetic population is diabetic retinopathy (DR). Many people could have their sight saved if only DR were detected and treated in time. Numerous Deep Learning (DL)-based methods have been presented to improve human analysis. Using a DL model with three scenarios, this research classified DR and its severity stages from fundus images using the "APTOS 2019 Blindness Detection" dataset. Following the adoption of the DL model, augmentation methods were implemented to generate a balanced dataset with consistent input parameters across all test scenarios. As a last step in the categorization process, the DenseNet-121 model was employed. Several methods, including Enhanced Super-resolution Generative Adversarial Networks (ESRGAN), Histogram Equalization (HIST), and Contrast Limited Adaptive HIST (CLAHE), have been used to enhance image quality in a variety of contexts. The suggested model detected the DR across all five APTOS 2019 grading process phases with the highest test accuracy of 98.36%, top-2 accuracy of 100%, and top-3 accuracy of 100%. Further evaluation criteria (precision, recall, and F1-score) for gauging the efficacy of the proposed model were established with the help of APTOS 2019. Furthermore, comparing CLAHE + ESRGAN against both state-of-the-art technology and other recommended methods, it was found that its use was more effective in DR classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.